Malondialdehyde and catalase as the serum biomarkers of allyl chloride-induced toxic neuropathy

Toxicology

Volumn 227, Issue 1-2, 2006, Pages 36-44

  Wang, Qing Shan ^a   Zhang, Cui Li ^a   Zhao, Xiu Lan ^a   Yu, Su Fang ^a   Xie, Ke Qin ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Allyl chloride (AC); CAT; Lipid peroxidation; MDA

Indexed keywords

ALLYL CHLORIDE; ANTIOXIDANT; BIOLOGICAL MARKER; CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEEDING; GAIT; INTOXICATION; LIPID PEROXIDATION; MALE; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; RAT; SCIATIC NERVE; SERUM; SYMPTOM;

ALLYL COMPOUNDS; ANIMALS; ANTIOXIDANTS; BIOLOGICAL MARKERS; CATALASE; ENVIRONMENTAL POLLUTANTS; GAIT; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; NEUROTOXICITY SYNDROMES; RATS; RATS, WISTAR; SCIATIC NERVE;

RATTUS NORVEGICUS;

EID: 33748753489     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2006.07.006     Document Type: Article

References (44)

1. Ahmed R.S., Seth V., Pasha S.T., and Banerjee B.D. Influence of dietary ginger (Zingiber officinales Rosc) on oxidative stress induced by malathion in rats. J. Food Chem. Toxicol. 38 (2000) 443-450
2. Banerjee B.D., Seth V., and Ahmed R.S. Pesticide-induced oxidative stress: perspective and trends. J. Rev. Environ. Health 16 (2001) 1-40
3. Beal M.F. Mitochondrial dysfunction in neurodegenerative diseases. Biochim. Biophys. Acta 1366 (1998) 211-223
4. Beal M.F. Mitochondria take center stage in aging and neurodegeneration. Ann. Neurol. 58 (2005) 495-505
5. Benzie I.F. Lipid peroxidation: a review of causes, consequences, measurement and dietary influences. Int. J. Food Sci. Nutr. 47 (1996) 233-261
6. Bhattachsrya A., Ghosal S., and Bhattacharya S.K. Anti-oxidant effect of withania somnifera glycowithanolides in chronic footshock stress-induced perturbations of oxidative free radical scavenging enzymes and lipid peroxidation in rat frontal cortex and striatum. J. Ethnopharmacol. 74 (2001) 1-6
7. Blake D.R., Allen R.E., and Lunee J. Free radicals in biological systems: a review oriented to the inflammatory process. Br. Med. Bull. 43 (1987) 371-385
8. Blumberg J. Use of biomarkers of oxidative stress in research studies. J. Nutr. 134 (2004) 3188S-3189S
9. Boaz M., Matas Z., Biro A., Katzir Z., Green M., Fainaru M., and Smetana S. Serum malondialdehyde and prevalent cardiovascular disease in hemodialysis. Kidney Int. 56 (1999) 1078-1083
10. Cleveland D.W. From Charcot to SOD1: mechanisms of selective motor neuron death in ALS. Neuron 24 (1999) 515-520
11. Costa L.G., and Manzo L. Biochemical markers of neurotoxicity: research strategies and epidemiological applications. Toxicol. Lett. 77 (1995) 137-144
12. Daschner M., Lenhartz H., Botticher D., Schaefer F., Wollschlager M., Mehls O., and Leichsenring M. Influence of dialysis on plasma lipid peroxidation products and antioxidant levels. Kidney Int. 50 (1996) 1268-1272
13. de Rooij B.M., Boogaard P.J., Commandeur J.N., van Sittert N.J., and Vermeulen N.P. Allylmercapturic acid as urinary biomarker of human exposure to allyl chloride. Occup. Environ. Med. 54 (1997) 653-661
14. Dotan Y., Lichtenberg D., and Pinchuk I. Lipid peroxidation cannot be used as a universal criterion of oxidative stress. Prog. Lipid Res. 43 (2004) 200-227
15. Gemignani F., Brindani F., Alfieri S., Giuberti T., Allegri I., Ferrari C., and Marbini A. Clinical spectrum of cryoglobulinaemic neuropathy. J. Neurol. Neurosurg. Psychiatry 76 (2005) 1410-1414
16. Gilbert S.G., and Maurissen J.P. Assessment of the effects of acrylamide, methylmercury, and 2,5-hexanedione on motor functions in mice. J. Toxicol. Environ. Health 10 (1982) 31-41
17. Graf M., Ecker D., Horowski R., Kramer B., Riederer P., Gerlach M., Hager C., Ludolph A.C., Kramer B., Ecker D., Becker G., Osterhage J., Jost W.H., Schrank B., Stein C., Kostopulos P., Lubik S., Wekwerth K., Dengler R., Troeger M., Wuerz A., Hoge A., Schrader C., Schimke N., Krampfl K., Petri S., Zierz S., Eger K., Neudecker S., Traufeller K., Sievert M., Neundorfer B., and Hecht M. High dose Vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study. J. Neural. Transm. 112 (2005) 649-660
18. Grundman M. Vitamin E and Alzheimer disease: the basis for additional clinical trials. Am. J. Clin. Nutr. 71 (2000) 630S-636S
19. Halliwell B., and Chirico S. Lipid peroxidation: its mechanism, measurement, and significance. Am. J. Clin. Nutr. 57 (1993) 724S-725S 715S-724S; discussion
20. He F.S., and Zhang S.L. Effects of allyl chloride on occupationally exposed subjects. Scand. J. Work Environ. Health 4 (1985) 43-45
21. He F.S., Shen D.G., Guo Y.P., and LU B.Q. Toxic polyneuropathy due to chronic allyl chloride intoxication: a clinical and experimental study. J. Chin. Med. J. 93 (1980) 177-182
22. He F., Jacobs J.M., and Scaravilli F. The pathology of allyl chloride neurotoxicity in mice. J. Acta Neuropathol. (Berl.) 55 (1981) 125-133
23. He F.S., Lu B.Q., Zhang S.L., Dong S.W., Yu A., and Wang B.Y. Chronic allyl chloride poisoning. An epidemiology, clinical toxicological and neuropathological study. G. Ital. Med. Lav. 7 (1985) 5-15
24. He Y., Nagano M., Yamamoto H., Miyamoto E., and Futatsuka M. Modifications of neurofilament proteins by possible metabolites of allyl chloride in vitro. Drug Chem. Toxicol. 18 (1995) 315-331
25. Honda K., Casadesus G., Petersen R.B., Perry G., and Smith M.A. Oxidative stress and redox-active iron in Alzheimer's disease. Ann. N. Y. Acad. Sci. 1012 (2004) 179-182
26. Ilic T.V., Jovanovic M., Jovicic A., and Tomovic M. Oxidative stress indicators are elevated in de novo Parkinson's disease patients. Funct. Neurol. 14 (1999) 141-147
27. Jenner P., and Olanow C.W. Oxidative stress and the pathogenesis of Parkinson's disease. Neurology 47 (1996) S161-S170
28. Jiang N., Hu Q., Reid C.S., Lu Y., and Li C.J. A novel palladium-catalyzed coupling of epoxides with allyl bromide mediated by indium(I) chloride: a cascade epoxide rearrangement-carbonyl allylation. Chem. Commun. (Camb.) 21 (2003) 2318-2319
29. Lagorio S., Tagesson C., Forastiere F., Iavarone I., Axelson O., and Carere A. Exposure to benzene and urinary concentrations of 8-hydroxydeoxyguanosine, a biological marker of oxidative damage to DNA. Occup. Environ. Med. 51 (1994) 739-743
30. Lehning E.J., Jortner B.S., Fox J.H., Arezzo J.C., Kitano T., and LoPachin R.M. gamma-diketone peripheral neuropathy. I. Quality morphometric analyses of axonal atrophy and swelling. J. Toxicol. Appl. Pharmacol. 165 (2000) 127-140
31. LoPachin R.M., Ross J.F., Reid M.L., Das S., Mansukhani S., and Lehning E.J. Neurological evaluation of toxic axonopathies in rats: acrylamide and 2,5-hexanedione. J. Neurotoxicol. 23 (2002) 95-110
32. Lu B.Q., Dong S.W., Yu A.R., Xian Y.L., Geng T.B., and Chui T. Studies on the toxicity of allyl chloride. J. Ecotoxicol. Environ. Saf. 6 (1982) 19-27
33. Mateos R., Lecumberri E., Ramos S., Goya L., and Bravo L. Determination of malondialdehyde (MDA) by high-performance liquid chromatography in serum and liver as a biomarker for oxidative stress. Application to a rat model for hypercholesterolemia and evaluation of the effect of diets rich in phenolic antioxidants from fruits. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 827 (2005) 76-82
34. McIntosh L.J., Trush M.A., and Troncoso J.C. Increased susceptibility of Alzheimer's disease temporal cortex to oxygen free radical-mediated processes. Free Radic. Biol. Med. 23 (1997) 183-190
35. Mercier M.J., and Robinson A.E. Use of biologic markers for toxic end-points in assessment of risks from exposure to chemicals. Int. Arch. Occup. Environ. Health 65 (1995) S7-S10
36. Nagano M., Yamamoto H., Harada K., Miyamoto E., and Futatsuka M. Comparative study of modification and degradation of neurofilament proteins in rats subchronically treated with allyl chloride, acrylamide, or 2,5-hexanedione. Environ. Res. 63 (1993) 229-240
37. Oteiza P.I., Uchitel O.D., Carrasquedo F., Dubrovski A.L., Roma J.C., and Fraga C.G. Evaluation of antioxidants, protein, and lipid oxidation products in blood from sporadic amyotrophic lateral sclerosis patients. Neurochem. Res. 22 (1997) 535-539
38. Pagot V., Malecaze F., Rotig A., Simorre V., Maillard P., Mathis A., and Munnich A. Leber's optic neuropathy: new diagnostic prospects. J. Fr. Ophtalmol. 15 (1992) 19-23
39. Rice-Evans C., and Burdon R. Free radical-lipid interactions and their pathological consequences. Prog. Lipid Res. 32 (1993) 71-110
40. Ripova D., and Strunecka A. An ideal biological marker of Alzheimer's disease: dream or reality?. Physiol. Res. 50 (2001) 119-129
41. Schmidt R.E., and Scharp D.W. Axonal dystrophy in experimental diabetic autonomic neuropathy. Diabetes 31 (1982) 761-770
42. Shaw G., Yang C., Ellis R., Anderson K., Parker Mickle J., Scheff S., Pike B., Anderson D.K., and Howland D.R. Hyperphosphorylated neurofilament NF-H is a serum biomarker of axonal injury. Biochem. Biophys. Res. Commun. 4 (2005) 1268-1277
43. Xie K., Sun K., Gao S., Zhang L., and Zhang M. Mechanism of allyl chloride-induced cytoskeletal injury to nerve cells. Chin. Med. J. (Engl.) 111 (1998) 556-559
44. Yarsan E., Tanyuksel M., Celik S., and Aydin A. Effect of aldicarb and malathion on lipid peroxidation. Bull. Environ. J. Contam. Toxicol. 63 (1999) 575-590